AVALO THERAPEUTICS, INC. Debt, Long-term and Short-term, Combined Amount
AVALO THERAPEUTICS, INC. (AVTX) had Debt, Long-term and Short-term, Combined Amount of $0 as of 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtLongtermAndShorttermCombinedAmount · last filed 2018-04-02
- 2017-12-31: Debt, Long-term and Short-term, Combined Amount $0.00.
- 2016-12-31: Debt, Long-term and Short-term, Combined Amount $2.35M.
- 2016-09-30: Debt, Long-term and Short-term, Combined Amount $3.19M.
- 2016-06-30: Debt, Long-term and Short-term, Combined Amount $4.00M.
| Period end | Debt, Long-term and Short-term, Combined Amount |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-12-31 | $2.35M 10-K · filed 2018-04-02 |
| 2016-09-30 | $3.19M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $4.00M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $4.79M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $5.56M 10-K · filed 2017-03-14 |
| 2015-09-30 | $6.32M 10-Q · filed 2015-11-13 |
| 2014-12-31 | $7.21M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |